The Enterprise Value as of January 2026 (TTM) for BriaCell Therapeutics Corp. (BCTX) is 5.46M

According to BriaCell Therapeutics Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 5.46M. This represents a change of -95.05% compared to the average of 110.25M of the last 4 quarters.

BriaCell Therapeutics Corp. (BCTX) Historical Enterprise Value (quarterly & annually)

How has BCTX Enterprise Value performed in the past?

The mean historical Enterprise Value of BriaCell Therapeutics Corp. over the last ten years is 371.59M. The current 5.46M Enterprise Value has changed 46.83% with respect to the historical average. Over the past ten years (40 quarters), BCTX's Enterprise Value was at its highest in in the July 2016 quarter at 2.99B. The Enterprise Value was at its lowest in in the July 2021 quarter at -56477114.00.

BriaCell Therapeutics Corp. (BCTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of BriaCell Therapeutics Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BriaCell Therapeutics Corp. (BCTX) Average Enterprise Value

How has BCTX Enterprise Value performed in the past?

The current Enterprise Value of BriaCell Therapeutics Corp. (BCTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

BriaCell Therapeutics Corp. (BCTX) Enterprise Value vs. Peers

How is BCTX’s Enterprise Value compared to its peers?

BriaCell Therapeutics Corp.’s Enterprise Value is greater than Processa Pharmaceuticals, Inc. (806.10K), less than Curis, Inc. (33.32M), less than Entero Therapeutics, Inc. (7.90M), less than Leap Therapeutics, Inc. (16.12M), less than Palisade Bio, Inc. (234.88M), greater than Hoth Therapeutics, Inc. (4.30M), greater than Allarity Therapeutics, Inc. (1.27M), greater than Moleculin Biotech, Inc. (-1137966.00), greater than Aspire Biopharma Holdings, Inc. (4.49M), less than Citius Pharmaceuticals, Inc. (6.17M),

Build a custom stock screener for BriaCell Therapeutics Corp. (BCTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BriaCell Therapeutics Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BriaCell Therapeutics Corp. (BCTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BriaCell Therapeutics Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.